Marlowe plc (LON:MRL - Get Free Report) reached a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 451 ($6.09) and last traded at GBX 438.92 ($5.93), with a volume of 5239475 shares traded. The stock had previously closed at GBX 441 ($5.96).
Analysts Set New Price Targets
Separately, Royal Bank Of Canada reaffirmed a "sector perform" rating and set a GBX 466 ($6.29) price objective on shares of Marlowe in a report on Wednesday, July 16th.
View Our Latest Research Report on Marlowe
Marlowe Stock Up 0.2%
The company has a market capitalization of £355.29 million, a P/E ratio of -41.29 and a beta of 0.44. The stock's fifty day moving average is GBX 421.17 and its 200 day moving average is GBX 361.91. The company has a current ratio of 1.24, a quick ratio of 0.80 and a debt-to-equity ratio of 58.99.
Marlowe (LON:MRL - Get Free Report) last released its quarterly earnings results on Thursday, June 26th. The company reported GBX 15.30 ($0.21) earnings per share for the quarter. Marlowe had a negative net margin of 2.03% and a negative return on equity of 2.33%. Research analysts predict that Marlowe plc will post 12.4863487 EPS for the current fiscal year.
About Marlowe
(
Get Free Report)
Marlowe is a leader in business-critical services and software which assure regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services and software. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation.
Featured Stories
Before you consider Marlowe, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marlowe wasn't on the list.
While Marlowe currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.